| Literature DB >> 28245825 |
Kyra Bartolo1, Martin Balzan2, Emma Louise Schembri2, Rachelle Asciak2, Darlene Mercieca Balbi2, Michael Pace Bardon2, Stephen Montefort2.
Abstract
BACKGROUND: Corret inhaler technique is recommended by guidelines for optimum asthma care. The objective of the study is to determine real life predictors of correct pressurized metered dose inhaler (pMDI) technique in Asthma and COPD patients.Entities:
Keywords: Critical step; Healthcare professional; Human error; Instruction; Medicinal efficacy
Mesh:
Substances:
Year: 2017 PMID: 28245825 PMCID: PMC5331728 DOI: 10.1186/s12890-017-0386-6
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Inhaler Technique check-list
| Step | pMDI + Spacer | pMDI |
|---|---|---|
|
| Remove the cap from the inhaler. | Remove the cap from the inhaler. |
|
|
|
|
|
| Insert the inhaler into the open end of the chamber and ensure that the inhaler fits properly. | Hold the inhaler firmly by placing your index finger on top of the canister, and thumb on the bottom of the mouthpiece. |
|
| Sit up straight or stand up. | Sit up straight or stand up. |
|
| Tilt your head back slightly. | Tilt your head back slightly. |
|
|
|
|
|
| Place the mouth piece in your mouth and seal your lips tightly around it. | Place the inhaler in your mouth and seal your lips tightly around it. |
|
|
|
|
|
| Remove spacer from the mouth. | Remove the inhaler from the mouth. |
|
|
|
|
|
| Exhale slowly. | Exhale slowly. |
|
| Remove the inhaler from the chamber and replace covers. | Replace cap on inhaler. |
Critical steps are shown in bold
Characteristics of patients using regular metered dose inhalers, and univariate comparison of 10 correct steps vs 3 errors or more, and no critical error vs critical errors
| All | 10–12 steps | <10steps |
| No critical error | critical error |
| |
|---|---|---|---|---|---|---|---|
| All | 208 | 133(63.9%) | 75(36.1%) | 67(32.2%) | 141(67.8%) | ||
|
|
|
|
|
| 31(46.3%) | 66(46.8%) | 0.94 |
| Mean age(STD) | 57.6(15.4) | 57(14.5) | 58.6(16.9) | 0.45 | 57.6(12.5) | 57.6(16.6) | 0.99 |
|
|
|
|
|
| 57(85.1%) | 107(75.9%) | 0.11 |
| Advised to use spacer | 170(81.7%) | 109(82%) | 61(81.3%) | 0.91 | 56(83.6%) | 114(80.9%) | 0.626 |
|
|
|
|
|
| 38(56.7%) | 94(66.7%) | 0.17 |
|
|
|
|
|
| 59(88.1%) | 121(85.8%) | 0.65 |
| LABA via aerolizer | 68(32.7%) | 43(32.3%) | 25(33.3%) | 0.88 | 19(28.4%) | 49(34.8%) | 0.35 |
| Inhaled ipratropium bromide | 38(18.3%) | 21(15.8%) | 17(22.7%) | 0.24 | 30(21.3%) | 8(11.9%) | 0.12 |
|
|
|
|
|
| 2.24(1.0) | 2.02(0.97) | 0.14 |
| Married status | 136(65.4%) | 92(69.2%) | 44(58.7%) | 0.13 | 48(71.6%) | 88(62.4%) | 0.18 |
| Smoker Y/N | 24(11.5%) | 13(9.8%) | 11(14.7%) | 0.31 | 7(10.4%) | 17(12.1%) | 0.72 |
| Resp physician Follow up | 144(69.2%) | 92(69.2%) | 52(69.3%) | 0.98 | 43(64.2%) | 101(71.6%) | 0.26 |
|
| 185(88.9%) | 118(88.7%) | 67(89.3%) | 0.89 | 63(94%) |
|
|
| Resp explained – number of times 1–7 | 3.37(2.8) | 4(2.70) | 3.37(2.62) | 0.16 | 3.9(2.64) | 3.74(2.71) | 0.28 |
| Resp physician time to explain 1–5 | 1.81(1.37) | 1.91(1.46) | 1.63(1.18) | 0.13 | 1.85(1.38) | 1.78(1.37) | 0.76 |
| GP follow up | 87(41.8%) | 54(40.6%) | 33(44%) | 0.94 | 27(40.3%) | 60(42.6%) | 0.8 |
| GP explained Y/N | 104(50%) | 69(51.9%) | 35(46.7%) | 0.47 | 32(47.8%) | 72(51.1% | 0.66 |
| GP explained times 0–7 | 1.43(2.19) | 1.40(2.12) | 1.48(3.27) | 0.8 | 1.36(2.12) | 1.46(2.22) | 0.75 |
| GP time to explain(0–5) | 0.97(1.25) | 1(1.27) | 0.92(1.23) | 0.66 | 0.96(1.33) | 0.98(1.22) | 0.9 |
| Any follow up | 187(89.9%) | 119(89.5%) | 68(90.7%) | 0.78 | 59(88.1%) | 128(90.8%) | 0.56 |
|
|
|
|
|
| 21(31.3%) | 39(27.7%) | 0.59 |
| Info-other source | 86(41.4%) | 56(42.1%) | 30(40%) | 0.77 | 31(46.3%) | 55(39%) | 0.37 |
|
|
|
|
|
| 2.01(1.46) | 1.82(1.65) | 0.4 |
|
|
|
|
|
| 7.96(2.21) | 7.7(2.28) | 0.434 |
| Perception as effective 1–5 | 2.45(0.8) | 2.4(0.735) | 2.48(0.84) | 0.47 | 2.4(0.74) | 2.48 | 0.47 |
| Ease of use 1–5 (SD) | 3.1(1.0) | 3.15(0.97) | 2.97(0.99) | 0.21 | 3.12(0.95) | 3.07(1.0) | 0.74 |
|
| 44(21.2%) | 30(22.6%) | 14(18.7%) | 0.6 |
|
|
|
| Diabetes | 34(16.35%) | 20(15%) | 14(18.7%) | 0.51 | 12(17.9%) | 22(15.6%) | 0.68 |
| Cholesterol | 59(28.4%) | 33(24.8%) | 26(34.7%) | 0.14 | 16(23.9%) | 43(30.5%) | 0.31 |
| Hypertension | 93(44.71%) | 56(42.1%) | 37(49.3%) | 0.32 | 30(44.8%) | 63(44.7%) | 0.99 |
|
|
|
|
|
|
|
|
|
| Influenza vaccine (current) | 121(58.2%) | 44(57.9%) | 77(58.7%) | 0.91 | 36(53.7%) | 85(60.3%) | 0.38 |
|
|
|
|
|
| 13(19.4%) | 27(19.1%) | 0.97 |
(p <0.1 shown in bold)
Fig. 1Percentage of patients having errors in pMDI inhaler technique. (n = 208)
Fig. 2Percentage number of patients with correct steps per step (n = 208). (Lower half of column indicates percentage participants performing step correctly, dark grey for non-critical steps, diagonal shading indicates critical steps)
Fig. 3Number of correct steps of inhaler technique. (Median and interquartile range shown at the bottom. Asterisks are outlier values)
Odd ratios for predictors of inhaler technique by binary logistic regression and stepwise selection
(grey numbers p > 0.05)
Predictors of correct steps of inhaler technique using ordinal logistic regression for all steps 0–12 and critical steps 0–4
| Predictor of correct steps (0–12) | Odds ratio | Lo95 | Up95 |
|
| Self score 1–10 | 1.25 | 1.1 | 1.42 | 0.001 |
| Education 1–4 | 1.6 | 1.16 | 2.2 | 0.004 |
| Observed to use spacer | 0.43 | 0.24 | 0.8 | 0.008 |
| GP explained | 3.3 | 1.35 | 8.09 | 0.009 |
| Male gender | 2.07 | 1.15 | 3.71 | 0.015 |
| Pneumococcal vaccine | 2.36 | 1.14 | 4.86 | 0.02 |
| Heart disease | 0.43 | 0.2 | 0.9 | 0.026 |
| Inhaled steroid use | 2.45 | 0.98 | 6.1 | 0.054 |
| Resp explained number of times | 1.11 | 0.99 | 1.25 | 0.068 |
| Any follow up | 0.38 | 0.12 | 1.22 | 0.104 |
| High cholesterol | 0.58 | 0.3 | 1.12 | 0.104 |
| Times explained by GP | 0.88 | 0.74 | 1.04 | 0.126 |
| Other healthcare-explained | 1.55 | 0.86 | 2.8 | 0.147 |
| Predictor of correct critical steps | Odds Ratio | Lo95 | Up95 |
|
| Self score 1–10 | 1.2 | 1.05 | 1.36 | 0.006 |
| Inhaled steroid use | 2.78 | 1.1 | 7.02 | 0.031 |
| Education 1–4 | 1.41 | 1.02 | 1.95 | 0.036 |
| High cholesterol | 0.52 | 0.26 | 1.01 | 0.054 |
| Male gender | 1.76 | 0.97 | 3.18 | 0.063 |
| Resp explained number of times | 1.1 | 0.98 | 1.24 | 0.101 |
| Observed to use spacer | 0.62 | 0.33 | 1.15 | 0.129 |
| Married status | 1.55 | 0.85 | 2.82 | 0.15 |